Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (11,679,154)	$ (12,770,222)
Adjustments to reconcile net loss from operations to net cash (used in) provided by operating activities:
Depreciation	3,829,345	4,364,166
Depreciation - discontinued operations	1,723,611	3,764,639
Amortization of intangible assets	189,329	95,076
Increase (decrease) in allowance for doubtful accounts	2,756,411	(45,979)
Increase in allowance for doubtful accounts - discontinued operations		2,107,570
Increase in reserve for obsolete inventories - discontinued operations		962,029
Loss on sale of subsidiary of discontinued operations	6,459,407
Loss from impairment of property and equipment - discontinued operations	1,660,305	7,016,658
Loss from sales contract dispute - discontinued operations		5,806,778
Stock-based compensation and fees	927,206	285,560
Changes in operating assets and liabilities:
Notes receivable	(10,537)	(25,734)
Accounts receivable	(5,906,749)	1,172,679
Inventories	(874,055)	1,469,282
Prepaid and other current assets	6,070	102,824
Advances to suppliers	(742,745)	(369)
Deferred tax assets	(188,090)	13,023
Assets of discontinued operations	2,659,512	(1,232,440)
Accounts payable	(958,163)	(707,293)
Accrued expenses	(173,030)	(82,642)
VAT and service taxes payable	(132,933)	(40,757)
Income taxes payable	(170,936)	(322,753)
Advances from customers	52,341	(67,055)
Liabilities of discontinued operations	(6,375,676)	(133,758)
Net cash (used in) provided by operating activities	(6,948,531)	11,731,282
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of patent use rights	(2,408,369)
Purchase of property and equipment	(1,209,477)	(12,458)
Payments made for equity method investment	(9,001,279)
Cash received from sale of subsidiary	2,167,532
Net cash used in investing activities	(10,451,593)	(12,458)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from bank loans	3,763,077	4,503,418
Repayments of bank loans	(3,838,338)	(4,342,581)
Decrease (increase) in restricted cash	60,209	(193,004)
Decrease (increase) in restricted cash - discontinued operations	(67,735)
(Decrease) increase in bank acceptance notes payable	(60,209)	193,004
Proceeds from sale of common stock	753,400
Net cash provided by financing activities	610,404	160,837
Effect of exchange rate changes on cash and cash equivalents	(519,152)	(925,082)
Net (decrease) increase in cash and cash equivalents	(17,308,872)	10,954,579
Cash and cash equivalents - beginning of year	18,790,370	7,835,791
Cash and cash equivalents - end of year	1,481,498	18,790,370
Cash paid in continuing operations for:
Interest	166,935	195,003
Income taxes	360,318	1,740,343
Cash paid in discontinued operations for:
Interest	48,250	40,363
Income taxes	189,570	536,954
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Stock issued for future services	9,074
Stock issued for accrued liabilities	54,000
Property and equipment acquired on credit as payable	15,263
Decrease in assets upon sale of subsidiary	14,673,414
Decrease in liabilities upon sale of subsidiary	1,012,452
Increase in receivable from sale of subsidiary	$ 7,225,107